ArticleEye (London, England)2025
Nonarteritic anterior ischemic optic neuropathy and the incidence of depression: a nationwide population-based study (2010-2017).
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND/
objectivesThe risk of depression in patients with non-arteritic anterior ischemic optic neuropathy (NAION) has yet to be thoroughly researched. This study aimed to investigate the association between NAION and the onset of depression using a large-scale nationwide cohort in South Korea.
methodsThis is a retrospective, nationwide cohort study involving 145,020 subjects without NAION and 29,004 individuals with a previous NAION diagnosis. Follow-up clinical data were collected until December 31, 2017. Multivariable adjustment models were employed to account for potential confounding factors.
resultsThe incidence of new-onset depression was significantly higher among NAION patients (incidence, 38.09 per 1000 person-years) than among non-NAION individuals (incidence, 29.91 per 1000 person-years). After adjusting for demographic factors, socioeconomic status, and comorbid diseases, the association remained significant (aHR = 1.271; 95% CI = 1.226-1.317). Notably, a subgroup analysis highlighted a particularly pronounced risk of depression in NAION patients aged 40 to 64 compared to those aged 65 or older (aHR = 1.34 vs. 1.207; interaction P = 0.0038).
conclusionOur findings demonstrate a significant association between NAION and an increased risk of depression, especially in relatively younger patients aged 40 to 64 years. These results highlight the importance of regular monitoring and early intervention for depressive symptoms in patients with NAION.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.